Chantarangkul V, van den Besselaar A M H P, Witteveen E, Tripodi A
Department of Internal Medicine, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, University and IRCCS Ospedale Maggiore, Mangiagalli and Regina Elena Foundation, Milan, Italy.
J Thromb Haemost. 2006 Jun;4(6):1339-45. doi: 10.1111/j.1538-7836.2006.01910.x.
A preparation of rabbit brain thromboplastin, provisionally coded 04/162, is proposed as a candidate for the World Health Organization (WHO) International Standard (IS) for thromboplastin (rabbit, plain), meant to replace the IS coded RBT/90 (rabbit, plain), stocks of which are now exhausted.
The preparation was calibrated in an international collaborative study involving 21 laboratories from 13 countries and the calibration was performed against the existing WHO-IS (i.e. rTF/95 and OBT/79) and other Certified Reference Materials from the Institute for Reference Materials and Measurements of the European Commission (i.e. CRM149 S) and from the European Action on Anticoagulation (i.e. EUTHR-01). An additional candidate rabbit brain thromboplastin coded as 04/106 was also included in the study. On the basis of predefined criteria (the within- and between-laboratory precision of the calibration and the conformity to the calibration model), 04/162 was the preferred candidate.
The assigned International Sensitivity Index value was 1.15 and the inter-laboratory SD and coefficient of variation were 0.057% and 4.9%, respectively.
一种兔脑凝血活酶制剂,临时编码为04/162,被提议作为世界卫生组织(WHO)凝血活酶(兔,普通)国际标准品(IS)的候选品,旨在取代现已耗尽库存的编码为RBT/90(兔,普通)的国际标准品。
该制剂在一项国际协作研究中进行了校准,该研究涉及来自13个国家的21个实验室,校准是对照现有的WHO国际标准品(即rTF/95和OBT/79)以及来自欧盟委员会参考物质与测量研究所的其他有证参考物质(即CRM149 S)和来自欧洲抗凝行动组织的参考物质(即EUTHR-01)进行的。另一种编码为04/106的候选兔脑凝血活酶也被纳入该研究。根据预定义标准(校准的实验室内和实验室间精密度以及与校准模型的符合性),04/162是首选候选品。
指定的国际敏感指数值为1.15,实验室间标准差和变异系数分别为0.057%和4.9%。